Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention

1 Dec 2023

Abstract excerpt

The profound impact of the human microbiome on health and disease has captivated the interest of clinical and scientific communities. The human body hosts a vast array of microorganisms collectively forming the human microbiome, which significantly influences various physiological processes and profoundly shapes overall well-being. Notably, the gut stands out as an exceptional reservoir, harboring the most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gastrointestinal motility and disorders
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38051964
DOI: 10.1093/cid/ciad639

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection PreventionPMID 38051964Read ↗

Probiotics: insights and new opportunities for Clostridioides difficile interventionSemantic proximity Read ↗

Development and Validation of a Novel Microbiome-Based Biomarker of Post-antibiotic Dysbiosis and Subsequent RestorationSemantic proximity Read ↗

Lyophilized fecal microbiome transfer for primary Clostridioides difficile infection: a multicenter randomized controlled trial (DONATE Study)Semantic proximity Read ↗

Toward the development of defined microbial therapeutics.Semantic proximity Read ↗

Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep SequencingSemantic proximity Read ↗

Antibiotic Treatments for Clostridium difficile Infection Are Associated with Distinct Bacterial and Fungal Community StructuresSemantic proximity Read ↗

Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation StrategiesSemantic proximity Read ↗

Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile InfectionSemantic proximity Read ↗

Analysis of the Intestinal Microbiome of a Recovered Clostridium difficile Patient after Fecal TransplantationSemantic proximity Read ↗

Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial ApplicationsSemantic proximity Read ↗

Successful Fecal Microbiota Transplants in Post-antibiotic Treated Recurrent Clostridioides difficile Patients Induce Acylcarnitine and Sphingolipid Lipidomic ShiftsSemantic proximity Read ↗

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent<i>Clostridium difficile</i>InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.